Fantao Meng

Director, Research & Development at HbO2 Therapeutics

Dr. Meng is a Hemoglobin specialist with 20 years of research experience in developing hemoglobin-based oxygen carriers (HBOCS). In 2014, he received ORISE-advanced scientist fellowship from FDA, and worked in the Biochemistry and Vascular Laboratory at the Office of Blood Research and Review for 5 years. Previously he spent 10 years as post-doctoral fellow/instructor at Albert Einstein College of Medicine. He holds a PhD from the National Key Lab of Biochemical Engineering, Chinese Academy of Sciences, China.


Org chart